Radiopharmaceuticals Third-Party Logistics Market Size to Reach USD 2,988.6 Million by 2034 at a 15.1% CAGR from 2026 to 2034
Radiopharmaceuticals third-party logistics industry size is estimated at USD 848.9 million in 2025 and forecasted to reach USD 2,988.6 million in 2034 with a CAGR of 15.1%. The radiopharmaceuticals third-party logistics market is witnessing strong growth driven by increasing demand for nuclear medicine procedures and expansion of precision oncology treatments.
Key Statistics:
- Market Size (2025): USD 848.9 Million
- Market Size (2034): USD 2,988.6 Million
- CAGR (2026-2034): 15.1%
- Dominating Region: North America
Report Highlights:
- Cold chain logistics dominated the market in 2025 by 34.98% revenue, due to strict temperature-control requirements associated with radiopharmaceutical transport.
- Hospitals segment dominated the market by 36.5% share in 2025, driven by rising volumes of PET imaging procedures and targeted radionuclide therapies.
- Time-critical logistics services projected to grow at the fastest CAGR of 15.7% during the forecast period, supported by increasing demand for rapid isotope transportation systems.
- North America dominated the market with 41.6% revenue share due to advanced healthcare infrastructure and strong adoption of nuclear medicine technologies.
- Asia Pacific radiopharmaceutical supply chain growth is projected to grow at the fastest CAGR of 15.6% during the forecast period, driven by increasing healthcare investments.
What’s Included in Radiopharmaceuticals Third-Party Logistics Report?
The report provides a detailed overview of the radiopharmaceuticals third-party logistics market based on service type and end user. It includes regional analysis, industry dynamics, and competitive landscape. The study also covers isotope transportation systems, cold chain infrastructure, digital shipment tracking, and healthcare logistics ecosystem developments.
What are Driving Factors and Emerging Trends of Radiopharmaceuticals Third-Party Logistics Market?
As per analysis, the market is expanding due to increasing cancer prevalence and rising adoption of nuclear medicine procedures. Key growth factors include:
- Rising Global Cancer Burden: Increasing incidence of cancer is driving higher demand for radiopharmaceuticals used in oncology diagnostics and targeted therapies. Healthcare providers are increasingly depending on specialized pharma logistics providers for reliable isotope delivery.
- Expansion of Theranostics and Personalized Medicine: Growing use of theranostics and precision medicine is increasing demand for highly specialized radiopharmaceutical distribution services and short half-life isotope logistics solutions.
- Integration of AI-Driven Logistics Optimization: AI-enabled predictive analytics and digital monitoring systems are improving shipment visibility, reducing isotope wastage, and enhancing delivery precision across radiopharmaceutical transport networks.
These trends indicate a strong shift toward advanced and technology-enabled nuclear medicine logistics systems.
Request a free sample copy or read the full market insights: Radiopharmaceuticals Third-Party Logistics Market Report
Which Key Segments are Driving Radiopharmaceuticals Third-Party Logistics Market?
By Service Type Analysis
Cold chain logistics segment accounted for the largest share in 2025 due to strict temperature management requirements associated with isotope stability and nuclear medicine transportation.
By End User Analysis
Hospitals segment dominated the market in 2025 driven by increasing volumes of oncology imaging procedures, PET scans, and targeted radionuclide therapies.
Which is Dominating Region in Radiopharmaceuticals Third-Party Logistics Market?
North America: North America led the market due to advanced healthcare systems, strong PET scan adoption, and increasing investment in precision molecular imaging technologies.
Asia Pacific: Asia Pacific is expected to grow at the fastest pace driven by increasing healthcare investments, expansion of isotope production facilities, and rising nuclear medicine adoption across China, India, and Japan.
Where is Radiopharmaceuticals Third-Party Logistics Market Headed?
According to analysis, the market is expected to witness strong expansion supported by increasing demand for theranostics, growth in precision oncology, and rising investments in advanced cold chain and digital logistics infrastructure.
What Radiopharmaceuticals Third-Party Logistics Market Report Reveals?
- What is the global market size, growth trend, and CAGR for the radiopharmaceuticals third-party logistics market through 2034?
- What are the key factors driving the growth of the radiopharmaceuticals third-party logistics market?
- Who are the major companies operating in the radiopharmaceuticals third-party logistics market, and how are they positioned competitively?
- How is increasing nuclear medicine adoption influencing logistics demand?
- What role do cold chain systems and AI-driven logistics technologies play in market expansion?
- What are the key regional trends across North America, Europe, and Asia Pacific?
- Where do new opportunities arise in the radiopharmaceuticals third-party logistics market?
Who are Major Radiopharmaceuticals Third-Party Logistics Market Contributors?
According to our study, a few firms are leading in the global market. The following are some of the major market contributors:
- Agility Public Warehousing Company K.S.C.
- AIT Worldwide Logistics, Inc.
- Alliance Healthcare
- AmerisourceBergen Corporation
- Cardinal Health, Inc.
- CEVA Logistics
- Curium Pharma LLC
- Deutsche Post DHL Group
- FedEx Corporation
- Kuehne + Nagel International AG
- McKesson Corporation
- SF Express Co., Ltd.
- UPS Supply Chain Solutions, Inc.
- United Parcel Service of America, Inc.
Market Segments Covered
By Service Type Outlook (Revenue, USD Million, 2021-2034)
- Cold Chain Logistics
- Time-Critical Logistics Services
- Regulatory Compliance Services
- Packaging & Monitoring Services
- Others
By End User Outlook (Revenue, USD Million, 2021-2034)
- Hospitals
- Diagnostic Centers
- Pharmaceutical & Biotechnology Companies
- Research Institutes
- Others
By Regional Outlook (Revenue, USD Million, 2021-2034)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherland
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Malaysia
- South Korea
- Indonesia
- Australia
- Rest of Asia Pacific
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Rest of Middle East & Africa
